| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Singh BB | |
| Mishra LC | |||
| Dagenais S | |||
| P433 | issue | 4 | |
| P921 | main subject | Withania somnifera | Q852660 |
| P304 | page(s) | 334-346 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Alternative Medicine Review | Q15279374 |
| P1476 | title | Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review | |
| P478 | volume | 5 |
| Q26774118 | A Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway Engineering |
| Q64110519 | A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males |
| Q37476283 | A holistic approach to the management of Erb's palsy |
| Q39767321 | A novel HSP90 modulator with selective activity against thyroid cancers in vitro |
| Q59336966 | A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide |
| Q37314302 | A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain |
| Q45409038 | Acaricidal activity of Cymbopogon winterianus, Vitex negundo and Withania somnifera against synthetic pyrethroid resistant Rhipicephalus (Boophilus) microplus. |
| Q35344031 | Advances in the research and development of natural health products as main stream cancer therapeutics |
| Q41958264 | Allelopathic effect of Ashwagandha against the germination and radicle growth of Cicer arietinum and Triticum aestivum |
| Q35145137 | An advocacy for Vaidya-Scientists in Ayurvedic research |
| Q34729658 | An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). |
| Q38023388 | An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda |
| Q33671229 | Anti-stress activity of hydro-alcoholic extract of Eugenia caryophyllus buds (clove). |
| Q38750417 | Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects |
| Q34778747 | Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus |
| Q43148712 | Antioxidant effect of dietary supplement Withania somnifera L. reduce blood glucose levels in alloxan-induced diabetic rats |
| Q37196355 | Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study |
| Q38813184 | AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models |
| Q35023273 | Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). |
| Q35978053 | Ashwagandha root in the treatment of non-classical adrenal hyperplasia |
| Q37251119 | Assessment of Cholinergic Properties of Ashwagandha Leaf-Extract in the Amnesic Mouse Brain |
| Q46306933 | Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment. |
| Q55281800 | Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects. |
| Q36424824 | Ayurvedic medicinal plants for Alzheimer's disease: a review |
| Q34878214 | Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells |
| Q90449036 | Bar-HRM: a reliable and fast method for species identification of ginseng (Panax ginseng, Panax notoginseng, Talinum paniculatum and Phytolacca Americana) |
| Q42566865 | Botanical Extracts from Rosehip (Rosa canina), Willow Bark (Salix alba), and Nettle Leaf (Urtica dioica) Suppress IL-1β-Induced NF-κB Activation in Canine Articular Chondrocytes |
| Q36088879 | Botanical immunodrugs: scope and opportunities. |
| Q54571598 | Changes in morphological phenotypes and withanolide composition of Ri-transformed roots of Withania somnifera. |
| Q36391065 | Changes in the leaf proteome profile of Withania somnifera (L.) Dunal in response to Alternaria alternata infection |
| Q31158688 | Characterization of Withania somnifera leaf transcriptome and expression analysis of pathogenesis-related genes during salicylic acid signaling. |
| Q80160722 | Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis |
| Q37393155 | Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males: A Pilot Study |
| Q64904659 | Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma. |
| Q47257511 | Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice |
| Q35668763 | Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin |
| Q35568686 | Development of withaferin A analogs as probes of angiogenesis |
| Q30455278 | Dietary and botanical anxiolytics. |
| Q28483352 | Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences |
| Q30835468 | Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS. |
| Q35064952 | Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis |
| Q37101683 | Effect of Withania somnifera (L.) Dunal on Sex Hormone and Gonadotropin Levels in Addicted Male Rats |
| Q41881431 | Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants |
| Q41254103 | Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults |
| Q53407271 | Effects of Withania somnifera on Reproductive System: A Systematic Review of the Available Evidence. |
| Q59793447 | Effects of an Aqueous Extract of on Strength Training Adaptations and Recovery: The STAR Trial |
| Q36533492 | Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclists |
| Q35520129 | Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. |
| Q90747352 | Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep: A Prospective, Randomized, Double-blind, Placebo-controlled Study |
| Q36393561 | Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults. |
| Q58601943 | Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin |
| Q35218471 | Enhanced biosynthesis of withanolides by elicitation and precursor feeding in cell suspension culture of Withania somnifera (L.) Dunal in shake-flask culture and bioreactor |
| Q34439695 | Erosive osteoarthritis: presentation, clinical pearls, and therapy |
| Q89964048 | Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook |
| Q34425281 | Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers |
| Q36242409 | Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system. |
| Q36317162 | Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial |
| Q26745772 | Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies |
| Q90382869 | Foliar application of elicitors enhanced the yield of withanolide contents in Withania somnifera (L.) Dunal (variety, Poshita) |
| Q28551962 | Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration |
| Q42654515 | Functional characterization and differential expression studies of squalene synthase from Withania somnifera. |
| Q37488585 | Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin |
| Q38710667 | Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia : A double blind randomized placebo-controlled trial |
| Q33826976 | Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A |
| Q55180127 | Hypertension in an Adolescent Secondary to Performance-Enhancement Supplement Use. |
| Q35206870 | Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach |
| Q37223968 | In Silico Analysis of Microarray-Based Gene Expression Profiles Predicts Tumor Cell Response to Withanolides |
| Q59350719 | In Vivo Evaluation of Withania somnifera-Based Indian Traditional Formulation ( Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia |
| Q33832474 | In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies |
| Q39672278 | In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β‐amyloid(1–42)‐induced cytotoxicity in differentiated PC12 cells |
| Q43119866 | Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation |
| Q33766743 | Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. |
| Q39624830 | LXR-α selectively reprogrammes cancer cells to enter into apoptosis |
| Q52768377 | Laboratory assessment of acaricidal activity of Cymbopogon winterianus, Vitex negundo and Withania somnifera extracts against deltamethrin resistant Hyalomma anatolicum. |
| Q88019123 | Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis |
| Q33853018 | Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells |
| Q36886410 | Management of tennis elbow by Agnikarma |
| Q33563815 | Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer |
| Q34039548 | Medicinal Plants and Other Living Organisms with Antitumor Potential against Lung Cancer |
| Q36557794 | Merger of ayurveda and tissue culture-based functional genomics: inspirations from systems biology |
| Q37079913 | Microbial secondary metabolites ameliorate growth, in planta contents and lignification in Withania somnifera (L.) Dunal |
| Q40997589 | Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer |
| Q37469387 | Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone |
| Q37151195 | Multimodal Ayurvedic management for Sandhigatavata (Osteoarthritis of knee joints). |
| Q28486400 | NADPH-cytochrome P450 reductase: molecular cloning and functional characterization of two paralogs from Withania somnifera (L.) dunal |
| Q26770401 | Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview |
| Q39369078 | Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation |
| Q21143741 | Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974 |
| Q46010920 | Neuroprotective effects of Withania somnifera dunal.: A possible mechanism. |
| Q86182755 | Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism |
| Q34175625 | Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A |
| Q37711241 | Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway. |
| Q52586079 | Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost. |
| Q47619930 | Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A. |
| Q38895762 | PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells |
| Q38573788 | Pharmacologic overview of Withania somnifera, the Indian Ginseng |
| Q24620472 | Pharmacological evaluation of Bioactive Principle of Turnera aphrodisiaca |
| Q37548974 | Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells |
| Q64983726 | Phytochemical Combination PB125 Activates the Nrf2 Pathway and Induces Cellular Protection against Oxidative Injury. |
| Q38771849 | Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes |
| Q88551082 | Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis |
| Q90369643 | Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings |
| Q33766685 | Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes |
| Q49070071 | Propensity of Withania somnifera to Attenuate Behavioural, Biochemical, and Histological Alterations in Experimental Model of Stroke |
| Q33630185 | Protection of swimming-induced oxidative stress in some vital organs by the treatment of composite extract of Withania somnifera, Ocimum sanctum and Zingiber officinalis in male rat. |
| Q33884074 | Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease |
| Q41202557 | Reversal of Cadmium-induced Oxidative Stress in Chicken by Herbal Adaptogens Withania Somnifera and Ocimum Sanctum |
| Q93172097 | Role of cytokines in combinatorial immunotherapeutics of non-small cell lung cancer through systems perspective |
| Q28475888 | Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling |
| Q36132585 | Short-form RON overexpression augments benzyl isothiocyanate-induced apoptosis in human breast cancer cells |
| Q35587729 | Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization |
| Q48274979 | Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development |
| Q42871834 | Stability indicating studies on NMITLI 118RT+ (standardized extract of withania somnifera dunal). |
| Q58098973 | Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS |
| Q37397036 | Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells |
| Q39418413 | Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis |
| Q36984582 | Sub-chronic safety evaluation of ayurvedic immunostimulant formulation 'immuforte' in rats in reverse pharmacology |
| Q47226952 | Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents |
| Q34482399 | Targeting Notch Signaling in Colorectal Cancer |
| Q35836876 | Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer |
| Q49733740 | The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells. |
| Q24633116 | The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin |
| Q82910201 | Therapeutic effect of Withania somnifera on pristane-induced model of SLE |
| Q57168345 | Third DWF1 paralog in Solanaceae, sterol Δ-isomerase, branches withanolide biosynthesis from the general phytosterol pathway |
| Q92323466 | Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice |
| Q34987033 | Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells |
| Q34828174 | Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo |
| Q34316709 | Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance |
| Q34253370 | Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells |
| Q36901996 | Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown |
| Q36091623 | Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. |
| Q36488146 | Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression |
| Q43113438 | Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury |
| Q33586011 | Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration. |
| Q50952029 | Withania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells. |
| Q89937669 | Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis |
| Q33979803 | Withania somnifera root extract extends lifespan of Caenorhabditis elegans. |
| Q33739134 | Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression |
| Q36984280 | Withania somnifera: From prevention to treatment of cancer |
| Q41699685 | Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells. |
| Q34305025 | Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90 |
| Q42004533 | WsSGTL1 gene from Withania somnifera, modulates glycosylation profile, antioxidant system and confers biotic and salt stress tolerance in transgenic tobacco |
| Q28545117 | β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A |
Search more.